Share
1,113 Posts.
lightbulb Created with Sketch. 10
clock Created with Sketch. 28/04/16
13:57
Share
Originally posted by jasetheace40
↑
I email Glyn this morning (before today's announcement). Here is my query:"I was keen to see the P&G update regarding the PDA and various work plans. It all looks positive for the company and so I am largely satisfied as a shareholder. I must, however, express my concern about the vagueness and lack of specifics regarding all of the various the projects in place. A lot of the announcement was also very confusing, particularly with the many references to "licenses", "licensing term sheets" (some "executed" and others not) "Wave I", "Wave II" - terms which themselves are somewhat vacuous without tangible products identified and any revenue figures forecast. It is obvious in the announcement that the company is forecasting the full commercial rollout of at least 2 or 3 products and, given OBJ is responsible for manufacturing the microarrays for each product, estimating the scale of the roll out is obviously within the company's capabilities. So it really doesn't seem a great leap to suggest that OBJ is also in a position to forecast revenue (with all the qualifications that obviously come with revenue forecast projections). So my query is really a simple one. When will the company provide any information relating to the actual revenue expected to be generated from P&G licenses to the market? As a shareholder this is what I am principally concerned about." "We have had to have this approved by P&G who are very sensitive about disclosing when the various products will be globally rolled out. G.D. Sent from my iPad"
Expand
This the bit I like... But we are very pleased with where we are at, multiple brands, multiple products, pretty good position all committed. And perhaps more to come.........
(20min delay)